HYA Advisors’s Pfizer PFE Stock Holding History

HYA Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$325K	Sell	6,196 -120	-2%	-$6.12K	0.13%	109
2022 Q1	$327K	Buy	6,316 +39	+0.6%	+$2.02K	0.11%	123
2021 Q4	$371K	Sell	6,277 -244	-4%	-$12.1K	0.13%	115
2021 Q3	$274K	Buy	6,521 +39	+0.6%	+$1.73K	0.11%	128
2021 Q2	$254K	Sell	6,482 -437	-6%	-$17K	0.11%	130
2021 Q1	$251K	Buy	6,919 +59	+0.9%	+$2.1K	0.12%	122
2020 Q4	$253K	Sell	6,860 -387	-5%	-$14.2K	0.13%	113
2020 Q3	$252K	Buy	+7,247	New	+$254K	0.15%	104
2020 Q1	–	Sell	-5,704	Closed	-$212K	–	109
2019 Q4	$212K	Buy	+5,704	New	+$203K	0.14%	106

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HYA Advisors's PFE Position: Q2 2022 in Review

HYA Advisors reduced its Pfizer (PFE) stake by 1.9% in Q2 2022, selling an estimated $6.12K and leaving 6,196 shares worth $325K. The position accounts for 0.13% of the portfolio, ranked #109.

HYA Advisors first reported a position in PFE in Q4 2019 and has held it in 9 quarters since. The position peaked at $371K in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

HYA Advisors held 6,196 shares of Pfizer worth $325K as of Q2 2022.
HYA Advisors sold 120 Pfizer shares in Q2 2022, an estimated $6.12K.
Pfizer made up 0.13% of HYA Advisors's portfolio in Q2 2022, its #109 holding.
HYA Advisors first reported a position in Pfizer in Q4 2019 and has held it in 9 quarters since.
HYA Advisors's Pfizer position peaked at $371K in Q4 2021.
3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on HYA Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.